Global Malaria Programme
The WHO Global Malaria Programme (GMP) is responsible for coordinating WHO's global efforts to control and eliminate malaria. Its work is guided by the "Global technical strategy for malaria 2016–2030" adopted by the World Health Assembly in May 2015 and updated in 2021.
Highlights
/word-malaria-report/wmr22-square.png?sfvrsn=e0f59733_9 "wmr22-square")
/act-small/malaria-guidelines-colour.jpg?sfvrsn=ca50c95b_19 "malaria-guidelines-colour")
/banner-wmd2023-gmp-web.tmb-1920v.jpg?sfvrsn=fed7fde7_5)
World Malaria Day 2023
"Time to deliver zero malaria: invest, innovate, implement"
Publications
All →The Global technical strategy for malaria 2016–2030 was adopted by the World Health Assembly in May 2015. It provides a comprehensive framework to...
On 18–20 April 2023, the WHO Malaria Policy Advisory Group (MPAG) convened to review updates and progress, and to provide guidance on thematic areas...
26 May 2023
Seasonal malaria chemoprevention with sulfadoxine–pyrimethamine plus amodiaquine in children: a field...
Seasonal malaria chemoprevention (SMC) is the intermittent administration of a curative dose of antimalarial medicine to children at high risk of severe...
20 April 2023
Monoclonal antibodies for malaria prevention
Preferred product characteristics (PPCs) are key tools to incentivize and guide the development of urgently needed health products. The PPCs published...
20 April 2023
Malaria chemoprevention
Preferred product characteristics” (PPCs) are key tools to incentivize and guide the development of urgently needed health products. The PPCs published...
Preferred product characteristics (PPCs) are key tools to incentivize and guide the development of urgently needed health products. This PPC was developed...
14 March 2023
WHO Guidelines for malaria
The WHO Guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate...
Ways to access malaria guidance
Clear, evidence-informed WHO recommendations are designed to guide countries as they develop national malaria strategic plans; they support decisions around “what to do”.
/in-page-highlights/malaria-magicapp-square.png?sfvrsn=5377a7ae_23 "malaria-magicapp-square")
/in-page-highlights/malaria-toolkit-app-square_e84ff510-2b45-4bcf-97a7-ac89aadf011d.jpg?sfvrsn=bbe7d3f2_23 "malaria-toolkit-app-square")
/in-page-highlights/malaria-video-square.jpg?sfvrsn=c28b8ff_12 "malaria-video-square")
/mme-images/mme-banner-small.jpg?sfvrsn=84d5cea_4 "mme-banner-small")
/malaria-vaccine-first-babies-500pix7b68b5bd00bf49a79517fea854f4cbf3_3becb335-06a4-43af-9b5b-56ef8683aef8.jpg?sfvrsn=41bda56f_25 "malaria-vaccine-first-babies-500pix")
/in-page-highlights/illustration-for-new-guidance.jpg?sfvrsn=396b72fa_3 "illustration-for-new-guidance")
/in-page-highlights/image-guideline-dev-process.jpg?sfvrsn=f593b4aa_23 "image-guideline-dev-process")